Laurus Labs Limited
Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and oral solid formulations for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It… Read more
Laurus Labs Limited (LAURUSLABS) - Total Assets
Latest total assets as of September 2025: ₹94.15 Billion INR
Based on the latest financial reports, Laurus Labs Limited (LAURUSLABS) holds total assets worth ₹94.15 Billion INR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Laurus Labs Limited - Total Assets Trend (2013–2025)
This chart illustrates how Laurus Labs Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Laurus Labs Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Laurus Labs Limited's total assets of ₹94.15 Billion consist of 46.4% current assets and 53.6% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹84.30 Million | 1.1% |
| Accounts Receivable | ₹20.41 Billion | 21.9% |
| Inventory | ₹19.37 Billion | 20.7% |
| Property, Plant & Equipment | ₹43.16 Billion | 46.2% |
| Intangible Assets | ₹193.20 Million | 0.2% |
| Goodwill | ₹2.46 Billion | 2.6% |
Asset Composition Trend (2013–2025)
This chart illustrates how Laurus Labs Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Laurus Labs Limited's current assets represent 46.4% of total assets in 2025, a decrease from 47.0% in 2013.
- Cash Position: Cash and equivalents constituted 1.1% of total assets in 2025, up from 0.4% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2013.
- Asset Diversification: The largest asset category is property, plant & equipment at 46.2% of total assets.
Laurus Labs Limited Competitors by Total Assets
Key competitors of Laurus Labs Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp Preferred
KO:000105
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
|
Yuyu Pharma
KO:000220
|
Korea | ₩202.42 Billion |
|
Ildong Holdings Co Ltd
KO:000230
|
Korea | ₩813.62 Billion |
Laurus Labs Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Laurus Labs Limited generates 0.59x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Laurus Labs Limited generates $ 3.84 in net profit.
Laurus Labs Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.32 | 1.19 | 1.22 |
| Quick Ratio | 0.68 | 0.58 | 0.57 |
| Cash Ratio | 0.02 | 0.01 | 0.00 |
| Working Capital | ₹10.16 Billion | ₹ 6.60 Billion | ₹ 3.84 Billion |
Laurus Labs Limited - Advanced Valuation Insights
This section examines the relationship between Laurus Labs Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 11.37 |
| Latest Market Cap to Assets Ratio | 0.04 |
| Asset Growth Rate (YoY) | 11.3% |
| Total Assets | ₹93.36 Billion |
| Market Capitalization | $4.02 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Laurus Labs Limited's assets below their book value (0.04 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Laurus Labs Limited's assets grew by 11.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Laurus Labs Limited (2013–2025)
The table below shows the annual total assets of Laurus Labs Limited from 2013 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | ₹93.36 Billion | +11.31% |
| 2024-03-31 | ₹83.87 Billion | +9.49% |
| 2023-03-31 | ₹76.60 Billion | +9.94% |
| 2022-03-31 | ₹69.68 Billion | +21.17% |
| 2021-03-31 | ₹57.51 Billion | +53.34% |
| 2020-03-31 | ₹37.50 Billion | +12.58% |
| 2019-03-31 | ₹33.31 Billion | +10.42% |
| 2018-03-31 | ₹30.17 Billion | +13.69% |
| 2017-03-31 | ₹26.53 Billion | +15.21% |
| 2016-03-31 | ₹23.03 Billion | +24.98% |
| 2015-03-31 | ₹18.43 Billion | +44.73% |
| 2014-03-31 | ₹12.73 Billion | +80.98% |
| 2013-03-31 | ₹7.03 Billion | -- |